Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-01-08
2008-01-08
Weber, Jon (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S014800, C514S015800, C514S016700, C530S328000, C530S327000, C530S329000, C530S350000, C435S069100, C435S252300, C435S254110
Reexamination Certificate
active
07317003
ABSTRACT:
The present invention provides peptides having potent anti-angiogenic activity and endothelial cell proliferation inhibition activity. The peptides can be administered as pharmaceutical compositions for prevention or treatment of undesired angiogenesis, for instance for prevention of tumor metastasis or inhibition of primary tumor growth.
REFERENCES:
patent: 5639725 (1997-06-01), O'Reilly et al.
patent: 5712380 (1998-01-01), Kendall
patent: 5801146 (1998-09-01), Davidson
patent: 5854205 (1998-12-01), Davidson
patent: 5972896 (1999-10-01), Davidson
patent: 5981484 (1999-11-01), Davidson
patent: 6057122 (2000-05-01), Davidson
patent: 09301888 (1997-11-01), None
patent: 10087509 (1998-04-01), None
patent: WO 94/25482 (1994-11-01), None
patent: WO 97/15660 (1997-05-01), None
patent: WO 97/41824 (1997-11-01), None
patent: WO 97/41824 (1997-11-01), None
patent: WO 00/26368 (2000-05-01), None
O'Reilly et al., Cell, vol. 88, pp. 277-285, Jan. 24, 1997.
Bowie et al., Science, vol. 247, pp. 1306-1310, 1990.
Houghten et al., Vaccines 86, Cold Spring Harbor Laboratory, pp. 21-25, 1986.
Dorland's Illustrated Medical Dictionary, Twenty-fift Edition, Published by W. B. Saunders, pgae 945, 1974.
Perletti et al. Antitumor Activity of Endostatin against Carcinogen-induced Rat Primary Mammary Tumors, Cancer Research, Apr. 1, 2001, vol. 60, pp. 1793-1796.
Judah Folkman et al, Cell, vol. 87, 1153-1156, Dec. 27, 1996.
Judah Folkman et al, Nature Medicine, vol. 1, No. 1, pp. 27-31 1999.
K. Jin Kim et al, Nature vol. 362, pp. 841-844, Apr. 29, 1993 Wanda Auerbach et al, Pharmac. Ther. vol. 63, pp. 265-311, 1994.
Judah Folkman, Cell, vol. 79, 315-328, Oct. 21, 1994.
Michael S. O'Reilly et al, Nature Medicine, vol. 2, No. 6, pp. 689-692 Jun. 1996.
Michael S. O'Reilly et al, Cell, vol. 88, 277-285, Jan. 24, 1997.
Thomas Boehm et al, Nature vol. 390 (27), pp. 404-407 Nov. 1997.
Robert S. Kerbel, Nature vol. 390 (27), pp. 335-336 Nov. 1997.
Robert Hardin et al, Heart Disease, A Textbook of Cardiovascular Medicine, eth Ed. pp. 1767-1789, E. Brunwald et al., c. 1992 by W.B. Saunders Co., Philadelphia, PA.
Birgit Millauer et al, Nature vol. 367, pp. 576-579 Feb. 10, 1994.
Yihai Cao et al, The Journal of Biological Chemistry vol. 271, No. 46, pp. 29461-29467, 1996.
Yihai Cao et al, vol. 272, No. 36, pp. 22924-22928, 1997.
R. Manjunatha Kini et al, Current Topics in Peptide & Prot. Res. 1, pp. 297-311 (1994).
R. Manjunatha Kini et al, BioChemical Biophysic vol. 212, No. 3, 1995, Jun. 26, 1995, pp. 1115-1124.
Suk Paul Oh et al, Proc. Natl. Acad. Sci. USA, vol. 91, pp. 4229-4233, May 1994.
Marko Rehn et al, Proc. Natl. Acad. Sci. USA. vol. 91, pp. 4234-4238, May 1994.
Y. Muragaki et al, Proc. Natl., Acad. Sci, USA. vol. 92, pp. 8763-8767, Sep. 1995.
Yuan-Hua Ding et al., Proc. Natl., Acad. Sci. USA vol. 95, pp. 10443-10448, Sep. 1998.
Thomas Boehm et al, Biochemistry and Biophysical Research Comm. 252, 190-194, (1998).
Napoleone Ferrara et al, Endocrine Reviews vol. 18, No. 1, 1997.
Bruce A. Keyt et al, The Journal of Biological Chemistry, vol. 271, pp. 5638-5646 1996.
Yves A. Muller et al. Proc. Natl. Acad. Sci. USA vol. 94, pp. 7192-7197, Jul. 1997.
Christian Wiesmann et al, Cell. vol. 91, 695-704 Nov. 28, 1997.
Bernhard Barleon et al, The Journal of Biological Chemistry, vol. 272, No. 16, pp. 10382-20388, 1997.
Sonia A. Cunningham, et al, Biochemistry and Biophysical Research Comm. 231, 596-599 (1997).
Hwai-Loonng Kong et al, Human Gene Therapy 9:823-833 (Apr. 10, 1998).
Yves A. Miller et al, Structure, 5:1325-1338, Oct. 15, 1997.
Wiesmann et al., Crystal Structure at 1.7 A° Resolution of VEGF in Complex with Domain 2 of the FLT-1 Receptor Cell, vol. 91, 695-704, Nov. 28, 1997.
Ge Ruowen
Kini R. Manjunatha
Birch & Stewart Kolasch & Birch, LLP
Mohamed Abdel A
National University of Singapore
Weber Jon
LandOfFree
Small peptides having anti-angiogenic and endothelial cell... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Small peptides having anti-angiogenic and endothelial cell..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Small peptides having anti-angiogenic and endothelial cell... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2805879